Company Search:
Advanced Search
Sponsored Links
4D Molecular Therapeutics LLC Company Snapshot
4D Molecular Therapeutics LLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares 4D Molecular Therapeutics LLC with three other companies in this sector in UNITED STATES : Kalvista Pharmaceuticals Inc (2020 sales of $12.69 million of which 100% was Pharmaceuticals), Inhibrx Inc ($12.89 million of which 100% was Biologic therapeutic candidates), and Kempharm Inc ($13.29 million of which 100% was Pharmaceutical company).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
4D Molecular Therapeutics LLC
  Stock Performance Chart for 4D Molecular Therapeutics LLC
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 38.70
(Figures in U.S. Dollars)
1 Week 13.7%   13 Weeks -3.3%  
4 Weeks -8.6%   52 Weeks n/a  
4D Molecular Therapeutics LLC Key Data:
  Ticker: FDMT Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 13,612,000
(Year Ending Jan 2021).
Employees: 83
  Currency: U.S. Dollars Market Cap: 1,032,592,742
  Fiscal Yr Ends: December Shares Outstanding: 26,681,983
  Share Type: Common Closely Held Shares: 4,678,306
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.